Glenmede Investment Management, LP Merck & Co., Inc. Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Glenmede Investment Management, LP holds 539,875 shares of MRK stock, worth $50.2 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
539,875
Previous 629,581
14.25%
Holding current value
$50.2 Million
Previous $49.8 Billion
99.91%
% of portfolio
0.23%
Previous 0.25%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,868Shares Held
1.97BCall Options Held
31.5MPut Options Held
31.5M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$7 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.56 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...